Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

1.

Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysis.

Teng YD, Benn SC, Kalkanis SN, Shefner JM, Onario RC, Cheng B, Lachyankar MB, Marconi M, Li J, Yu D, Han I, Maragakis NJ, Lládo J, Erkmen K, Redmond DE Jr, Sidman RL, Przedborski S, Rothstein JD, Brown RH Jr, Snyder EY.

Sci Transl Med. 2012 Dec 19;4(165):165ra164. doi: 10.1126/scitranslmed.3004579.

PMID:
23253611
[PubMed - indexed for MEDLINE]
2.

Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model.

Nizzardo M, Simone C, Rizzo F, Ruggieri M, Salani S, Riboldi G, Faravelli I, Zanetta C, Bresolin N, Comi GP, Corti S.

Hum Mol Genet. 2014 Jan 15;23(2):342-54. doi: 10.1093/hmg/ddt425. Epub 2013 Sep 4.

PMID:
24006477
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Functional neural stem cell isolation from brains of adult mutant SOD1 (SOD1(G93A)) transgenic amyotrophic lateral sclerosis (ALS) mice.

Lee JC, Jin Y, Jin J, Kang BG, Nam DH, Joo KM, Cha CI.

Neurol Res. 2011 Jan;33(1):33-7. doi: 10.1179/016164110X12807570509899. Epub 2010 Aug 31.

PMID:
20810028
[PubMed - indexed for MEDLINE]
4.

Neural induction with neurogenin 1 enhances the therapeutic potential of mesenchymal stem cells in an amyotrophic lateral sclerosis mouse model.

Chan-Il C, Young-Don L, Heejaung K, Kim SH, Suh-Kim H, Kim SS.

Cell Transplant. 2013;22(5):855-70.

PMID:
22472631
[PubMed - indexed for MEDLINE]
5.

Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.

Corti S, Locatelli F, Papadimitriou D, Del Bo R, Nizzardo M, Nardini M, Donadoni C, Salani S, Fortunato F, Strazzer S, Bresolin N, Comi GP.

Brain. 2007 May;130(Pt 5):1289-305. Epub 2007 Apr 17.

PMID:
17439986
[PubMed - indexed for MEDLINE]
Free Article
6.

Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice.

Zhao CP, Zhang C, Zhou SN, Xie YM, Wang YH, Huang H, Shang YC, Li WY, Zhou C, Yu MJ, Feng SW.

Cytotherapy. 2007;9(5):414-26.

PMID:
17786603
[PubMed - indexed for MEDLINE]
7.

The adult neural stem and progenitor cell niche is altered in amyotrophic lateral sclerosis mouse brain.

Liu Z, Martin LJ.

J Comp Neurol. 2006 Jul 20;497(3):468-88.

PMID:
16736475
[PubMed - indexed for MEDLINE]
8.

Distribution, differentiation, and survival of intravenously administered neural stem cells in a rat model of amyotrophic lateral sclerosis.

Mitrecić D, Nicaise C, Gajović S, Pochet R.

Cell Transplant. 2010;19(5):537-48. doi: 10.3727/096368910X498269. Epub 2010 Mar 26.

PMID:
20350352
[PubMed - indexed for MEDLINE]
9.

In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.

Niessen HG, Angenstein F, Sander K, Kunz WS, Teuchert M, Ludolph AC, Heinze HJ, Scheich H, Vielhaber S.

Exp Neurol. 2006 Oct;201(2):293-300. Epub 2006 Jun 5.

PMID:
16740261
[PubMed - indexed for MEDLINE]
10.

Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice.

Yan J, Xu L, Welsh AM, Chen D, Hazel T, Johe K, Koliatsos VE.

Stem Cells. 2006 Aug;24(8):1976-85. Epub 2006 Apr 27.

PMID:
16644922
[PubMed - indexed for MEDLINE]
Free Article
11.

Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models.

Kato S, Kato M, Abe Y, Matsumura T, Nishino T, Aoki M, Itoyama Y, Asayama K, Awaya A, Hirano A, Ohama E.

Acta Neuropathol. 2005 Aug;110(2):101-12. Epub 2005 Jun 28.

PMID:
15983830
[PubMed - indexed for MEDLINE]
12.

Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects.

Habisch HJ, Janowski M, Binder D, Kuzma-Kozakiewicz M, Widmann A, Habich A, Schwalenstöcker B, Hermann A, Brenner R, Lukomska B, Domanska-Janik K, Ludolph AC, Storch A.

J Neural Transm. 2007;114(11):1395-406. Epub 2007 May 18.

PMID:
17510731
[PubMed - indexed for MEDLINE]
13.

Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.

Shibata N.

Neuropathology. 2001 Mar;21(1):82-92. Review.

PMID:
11304046
[PubMed - indexed for MEDLINE]
14.

Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.

Tanaka K, Kanno T, Yanagisawa Y, Yasutake K, Hadano S, Yoshii F, Ikeda JE.

Exp Neurol. 2011 Nov;232(1):41-52. doi: 10.1016/j.expneurol.2011.08.001. Epub 2011 Aug 16.

PMID:
21867702
[PubMed - indexed for MEDLINE]
15.

Vacuolization correlates with spin-spin relaxation time in motor brainstem nuclei and behavioural tests in the transgenic G93A-SOD1 mouse model of ALS.

Bucher S, Braunstein KE, Niessen HG, Kaulisch T, Neumaier M, Boeckers TM, Stiller D, Ludolph AC.

Eur J Neurosci. 2007 Oct;26(7):1895-901. Epub 2007 Sep 14.

PMID:
17868365
[PubMed - indexed for MEDLINE]
16.

A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice.

Teuling E, van Dis V, Wulf PS, Haasdijk ED, Akhmanova A, Hoogenraad CC, Jaarsma D.

Hum Mol Genet. 2008 Sep 15;17(18):2849-62. doi: 10.1093/hmg/ddn182. Epub 2008 Jun 25.

PMID:
18579581
[PubMed - indexed for MEDLINE]
Free Article
17.

Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome.

Alves CJ, de Santana LP, dos Santos AJ, de Oliveira GP, Duobles T, Scorisa JM, Martins RS, Maximino JR, Chadi G.

Brain Res. 2011 Jun 7;1394:90-104. doi: 10.1016/j.brainres.2011.02.060. Epub 2011 Feb 24.

PMID:
21354109
[PubMed - indexed for MEDLINE]
Free Article
18.

Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice.

Park S, Kim HT, Yun S, Kim IS, Lee J, Lee IS, Park KI.

Exp Mol Med. 2009 Jul 31;41(7):487-500. doi: 10.3858/emm.2009.41.7.054.

PMID:
19322031
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues.

Corti S, Locatelli F, Donadoni C, Guglieri M, Papadimitriou D, Strazzer S, Del Bo R, Comi GP.

Brain. 2004 Nov;127(Pt 11):2518-32. Epub 2004 Oct 6.

PMID:
15469951
[PubMed - indexed for MEDLINE]
Free Article
20.

Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.

Bryson JB, Hobbs C, Parsons MJ, Bosch KD, Pandraud A, Walsh FS, Doherty P, Greensmith L.

Hum Mol Genet. 2012 Sep 1;21(17):3871-82. doi: 10.1093/hmg/dds215. Epub 2012 Jun 7.

PMID:
22678056
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk